MPWT
HUMA icon

MassMutual Private Wealth & Trust’s Humacyte HUMA Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-765
Closed -$735 – 2435
2025
Q4 		$735 Hold
765
– – ﹤0.01% 2195
2025
Q3 		$1.33K Hold
765
– – ﹤0.01% 2092
2025
Q2 		$1.6K Buy
+765
New +$1.47K ﹤0.01% 2017

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AP
Antipodes Partners Royal Exchange, Australia $5.19B AUM 36.17% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

MassMutual Private Wealth & Trust's HUMA Position: Q1 2026 in Review

MassMutual Private Wealth & Trust sold out of Humacyte (HUMA) in Q1 2026, closing a stake of 765 shares — an estimated $735 sold.

MassMutual Private Wealth & Trust first reported a position in HUMA in Q2 2025 and held it in 3 quarters. The position peaked at $1.6K in Q2 2025. 158 funds tracked by Wall St. Rank hold HUMA as of Q1 2026.

  • MassMutual Private Wealth & Trust reported no remaining Humacyte position as of Q1 2026 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 765 Humacyte shares in Q1 2026, an estimated $735.
  • MassMutual Private Wealth & Trust first reported a position in Humacyte in Q2 2025 and held it in 3 quarters.
  • MassMutual Private Wealth & Trust's Humacyte position peaked at $1.6K in Q2 2025.
  • 158 funds tracked by Wall St. Rank held Humacyte as of Q1 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q1 2026, filed 13 Apr 2026.